R2101259 |
SGK3 degrader-1 |
PROTAC SGK3 degrader-1 (SGK3-PROTAC1) is a PROTAC conjugate of the 308-R SGK inh
|
R2101260 |
VH032-C4-NH2 dihydrochloride |
(S,R,S)-AHPC-C4-NH2 dihydrochloride is a synthesized E3 ligase ligand-linker con
|
R2101261 |
XZ739 |
XZ739 is a CRBN-based PROTAC Bcl-XL decompressant, which acts on Molt-4 cells. A
|
R2101262 |
INNO206 |
|
R2101263 |
TL12-186 |
TL12-186 is a CRBN-dependent multi-kinase PROTAC decompressor.Including CDK, BTK
|
R2101265 |
TL13-12 |
TL13-12 is a selective degrader of ALK-PROTAC and inhibits ALK activity (IC50: 0
|
R2101266 |
VH032-C5-COOH |
(S,R,S)-AHPC-C5-COOH (VH032-C5-COOH) is a synthesized E3 ligase ligand-linker co
|
R2101267 |
TD-165 |
TD-165 is a PROTAC-based cereblon (CRBN) degrader. TD-165 comprises a cereblon (
|
R2101268 |
BAY-1797 |
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against
|
R2101269 |
Sparsentan |
Sparsentan is a first-in-class orally active and highly potent dual endothelin A
|
R2101270 |
Ripretinib |
Ripretinib is an orally bioavailable inhibitor of KIT and PDGFRA.
|
R2101271 |
Larotrectinib sulfate(LOXO101) |
LOXO-101 is an oral active and specific ATP-competitive inhibitor of tropomyosin
|
R2101257 |
UNC6852 |
UNC6852 is a selective degrader that targets polycomb repressive complex 2 (PRC2
|
R21042801 |
Bexarotene |
Bexarotene is a selective retinoid X receptor (RXR) agonist used to treat cutane
|
R21042802 |
Pentoxyverine Citrate |
Carbetapentane citrate has a selective inhibitory effect on the cough center, wi
|
R21042804 |
HISPIDIN |
Hispidin is a PKC inhibitor, a phenolic compound from Phelinus linteus that has
|
R21042805 |
Dexpramipexole |
Dexpramipexole(KNS-760704), also known as R-(+) -pramipexole, is a neuroprotecti
|
R21042806 |
Efaproxiral sodium |
Efaproxiral sodium is an allosteric regulator of hemoglobin (Hb) synthesis that
|
R21042807 |
Trandolaprilat |
Trandolaprilat is a non-sulfhydryl angiotensin-converting enzyme inhibitor.
|
R21042808 |
naltrexone |
A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of
|
R21042809 |
ROCAGLAMIDE |
Rocaglamide is a potent inhibitor of NF-κB activation.
|
R21042810 |
MSA-2 |
MSA-2 is an oral nonnucleotide STING agonist with an EC50 of 8.3 μM for human ST
|
R21042811 |
LY-2183240 |
LY2183240 is a highly active cannabinoid absorbance blocker with an IC50 of 270
|
R21042812 |
DS-1206b |
|
R21042813 |
Phthalazinone pyrazole |
Phthalazinone pyrazole is a potent inhibitor of Aurora A kinase with IC50 of 31
|